
Maneesh Sud
MD PhD
Clinician-scientist
maneesh.sud@sunnybrook.ca
Sunnybrook Health Sciences Centre
Phone: 416-480-6066
Fax: 416-480-6174
Clinical Assistant:
Research Assistant:
Dr. Sud’s research focuses on identifying care gaps and developing innovative solutions to improve the delivery of evidence-based treatments across the spectrum of patients with coronary artery disease.
Education
- BSc, 2007, University of Toronto, Canada
- MD, 2011, University of Manitoba, Canada
- Residency, 2014, Internal Medicine, University of Toronto, Canada
- Fellowship, 2017, Cardiology, University of Toronto, Canada
- Fellowship, 2019, Interventional Cardiology, Sunnybrook Health Sciences Centre, Canada
- PhD, 2023, Institute of Health Policy, Management and Evaluation, University of Toronto, Canada
Appointments and Affiliations
- Scientist, Evaluative Clincial Sciences, Schulich Heart Research Program, Sunnybrook Research Institute
- Staff Cardiologist, Division of Cardiology, Department of Medicine, Sunnybrook Health Sciences Centre
- Assistant Professor, Department of Medicine, University of Toronto
Research Foci
- Cardiovascular Health Outcomes Research
- Primary and Secondary Prevention
Publications
Affiliated Labs & Programs
Selected Publications
-
Development and Validation of the CANHEART Population-Based Laboratory Prediction Models for Atherosclerotic Cardiovascular Disease. Sud M, Sivaswamy A, Austin PC, Anderson TJ, Naimark DMJ, Farkouh ME, Lee DS, Roifman I, Thanassoulis G, Tu K, Udell JA, Wijeysundera HC, Ko DT. Ann Intern Med. 2023 Dec;176(12):1638-1647.
-
Population-Based Recalibration of the Framingham Risk Score and Pooled Cohort Equations. Sud M, Sivaswamy A, Chu A, Austin PC, Anderson TJ, Naimark DMJ, Farkouh ME, Lee DS, Roifman I, Thanassoulis G, Tu K, Udell JA, Wijeysundera HC, Ko DT. J Am Coll Cardiol. 2022 Oct 4;80(14):1330-1342.
-
Association Between Adherence to Fractional Flow Reserve Treatment Thresholds and Major Adverse Cardiac Events in Patients With Coronary Artery Disease. Sud M, Han L, Koh M, Austin PC, Farkouh ME, Ly HQ, Madan M, Natarajan MK, So DY, Wijeysundera HC, Fang J, Ko DT. JAMA. 2020 Dec 15;324(23):2406-2414.
-
Low-Density Lipoprotein Cholesterol and Adverse Cardiovascular Events After Percutaneous Coronary Intervention. Sud M, Han L, Koh M, Abdel-Qadir H, Austin PC, Farkouh ME, Godoy LC, Lawler PR, Udell JA, Wijeysundera HC, Ko DT. J Am Coll Cardiol. 2020 Sep 22;76(12):1440-1450.
-
Risk of end-stage renal disease and death after cardiovascular events in chronic kidney disease. Sud M, Tangri N, Pintilie M, Levey AS, Naimark D. Circulation. 2014 Aug 5;130(6):458-65.
In the News
-
New research will help personalize cardiac prevention therapies in the future
October 4, 2022
-
Study Shows Relation of LDL Cholesterol Levels and PCI Outcomes
September 14, 2020